Workers' Comp
COVID-19 Drug Therapy Treatments: Potential Impact on Workers' Comp
May 7, 2020
MIN READ
More stories
Workers' Comp
Article
Communication is Key to Ending Disparity
A couple years ago, Genex surveyed our case managers to determine the common claims pitfalls they avoid to keep claims on track. Among the top five factors were two that seemed relatively easy to remedy: communication issues and patient noncompliance.
Risk & Insurance
In the News
Building Trust With Injured LGBTQ Employees
Learn how inclusive communication and culturally competent care can build trust and improve outcomes for injured LGBTQ+ employees in workers’ compensation.
Workers' Comp
White Paper
Value-Based Contracting
Value-based contracting (VBC) is one of the most talked-about topics at conferences, in stewardship meetings, and in workers’ compensation requests for proposal (RFPs). But for all the discussion around the term, one thing seems missing: a common definition. VBC seems fairly straight-forward to most observers and that might be part of the problem. Indeed, ask a half dozen people what value-based contracting means and you’ll get as many answers.
Workers' Comp
Article
Beyond Boundaries: How an Injured Worker Became an Inspiration for All
As a case manager, a big part of my job is to motivate and advocate for injured workers. However, I often find that my inspiration to meet these goals stems from the workers themselves. Such is the case with Todd Eckley, a land surveyor who sustained an incomplete C6-7 fracture, leaving him paralyzed from the waist down and with limited use of his hands.
Workers' Comp
Blog
Beyond Boundaries: How an Injured Worker Became an Inspiration for All
As a case manager, a big part of my job is to motivate and advocate for injured workers.
Workers' Comp
Article
Opioid Management in Workers’ Comp: Is Case Management the Missing Link?
Opioid abuse has been in the crosshairs of workers’ comp regulators for the past decade. While there have been some hits and misses in the industry’s attempts to control these substances, gaining a better understanding of the roots of the problem and what companies are doing to address it, has led to better solutions. That’s why I was fascinated with the recent piece by noted columnist Peter Rousmaniere, “Getting Off Opioids.”